| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
14,713 |
11,888 |
$2.40M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,866 |
1,313 |
$39K |
| 87428 |
|
461 |
335 |
$22K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
385 |
356 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,500 |
1,171 |
$7K |
| 90686 |
|
69 |
68 |
$1K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
20 |
14 |
$758.16 |
| 90619 |
|
32 |
28 |
$260.44 |
| 36415 |
Collection of venous blood by venipuncture |
541 |
487 |
$148.64 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
109 |
101 |
$32.00 |
| 81025 |
|
12 |
12 |
$27.09 |
| 81003 |
|
165 |
150 |
$18.03 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
308 |
290 |
$0.01 |
| 81002 |
|
138 |
129 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
179 |
173 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
163 |
100 |
$0.00 |
| 1000F |
|
21 |
17 |
$0.00 |
| 90694 |
|
13 |
13 |
$0.00 |
| T1014 |
Telehealth transmission, per minute, professional services bill separately |
13 |
12 |
$0.00 |
| 1220F |
|
18 |
15 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$0.00 |
| 99441 |
|
15 |
15 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$0.00 |